Open Access<p>Not All Hepatocellular Carcinoma Patients with Microvascular Invasion After R0 Resection Could Be Benefited from Prophylactic Transarterial Chemoembolization: A Propensity Score Matching Study</p>
Author(s) -
Lei Wang,
Kongying Lin,
Jingbo Chen,
Wenhua Ren,
Chunhong Xiao,
Xiaolong Liu,
Jingfeng Liu
Publication year - 2020
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s251605
Subject(s) - medicine , propensity score matching , hepatocellular carcinoma , gastroenterology , cohort , grading (engineering) , liver cancer , proportional hazards model , overall survival , subgroup analysis , multivariate analysis , capsule , hepatectomy , stage (stratigraphy) , survival analysis , carcinoma , surgery , resection , confidence interval , civil engineering , botany , engineering , biology , paleontology
Prophylactic transarterial chemoembolization (p-TACE) is strongly recommended for hepatocellular carcinoma (HCC) patients with microvascular invasion (MVI), but the potential beneficiaries remain controversial.